tag:blogger.com,1999:blog-2335748440449035592.post177230868188237236..comments2007-11-13T14:41:27.922-05:00TraderMarkhttp://www.blogger.com/profile/06241756200482130281noreply@blogger.comBlogger4125tag:blogger.com,1999:blog-2335748440449035592.post-39729569512154412922007-11-13T14:41:00.000-05:002007-11-13T14:41:00.000-05:00Citi: $56 -> $64 (buy -> hold)<BR/>Calyon: -> $66 (add -> buy)<BR/>DA Davidson: $60 -> $63 (neutral -> neutral)msbnoreply@blogger.comtag:blogger.com,1999:blog-2335748440449035592.post-49459519955674383312007-11-13T13:08:00.000-05:002007-11-13T13:08:00.000-05:00got it<BR/>like I said, just sounds like an excuse to sell<BR/>any idea on 'target price' - just curious.<BR/>MDR will be a good buy again... FWLT was sold last quarter initially because of a lumpy quarter and then it went on and did great things... but the near term other opportunities abound.TraderMarkhttp://www.blogger.com/profile/06241756200482130281noreply@blogger.comtag:blogger.com,1999:blog-2335748440449035592.post-56699902719592006752007-11-13T12:07:00.000-05:002007-11-13T12:07:00.000-05:00The downgrade from Citi (with a target price increase) came because of the revenue numbers and valuation, plus Cramer emphatically said he didn't like it (something about how they "missed badly"...), so down MDR went. The upgrade from Calyon seems to not have had much of an effect so far.<BR/><BR/>From the Citi statement: "<I>We are lowering our EPS outlook by reducing our gross margin assumptions. Our target price is up to account for higher forward commodity prices since our last<BR/>update. The net effect is a target price that is higher but a total return that does not merit an accretive stance. </I>"msbnoreply@blogger.comtag:blogger.com,1999:blog-2335748440449035592.post-22508576618466409292007-11-13T10:52:00.000-05:002007-11-13T10:52:00.000-05:00McDermott upgraded by Calyon Securities<BR/>Briefing.com (Tue 7:06am)fortune8http://www.blogger.com/profile/12397351520040152701noreply@blogger.com